Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing

Biomaterials

Volumn 78, Issue , 2016, Pages 27-39

  Wang, Bei Ke ^a   Yu, Xue Feng ^b   Wang, Jia Hong ^a   Li, Zhi Bin ^b   Li, Peng Hui ^b,d   Wang, Huaiyu ^b   Song, Li ^c   Chu, Paul K ^d   Li, Chengzhang ^a  

^a WUHAN UNIVERSITY   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c NANCHANG UNIVERSITY   (China)

^d CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomedical applications; Gold nanorods; Oral cancer; Photothermal therapy; RNA interference

Indexed keywords

CELL DEATH; CELLS; DISEASES; EFFICIENCY; GENE TRANSFER; GENES; GENETIC ENGINEERING; GOLD; HEAT RESISTANCE; LIPOSOMES; MEDICAL APPLICATIONS; NANORIBBONS; NANORODS; PLASMONS; SURFACE TREATMENT;

BIOMEDICAL APPLICATIONS; GOLD NANOROD; ORAL CANCER; PHOTOTHERMAL THERAPY; RNA INTERFERENCE;

GENE THERAPY;

GOLD; NANOTUBE; SMALL INTERFERING RNA;

CHEMISTRY; GENE SILENCING; HUMAN; PHOTOTHERAPY; THERMOTHERAPY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE SILENCING; GOLD; HUMANS; HYPERTHERMIA, INDUCED; NANOTUBES; PHOTOTHERAPY; RNA, SMALL INTERFERING;

EID: 84949999070     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.11.025     Document Type: Article

References (79)

1. Chen W.R., Adams R.L., Carubelli R., Nordquist R.E. Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. Cancer Lett. 1997, 115:25-30.
2. Castren-Persons M., Schroder T., Ramo O.J., Puolakkainen P., Lehtonen E. Contact Nd:YAG laser potentiates the tumor cell killing effect of hyperthermia. Laser Surg. Med. 1991, 11:595-600.
3. Huff T.B., Tong L., Zhao Y., Hansen M.N., Cheng J.X., Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2007, 2:125-132.
4. Dickerson E.B., Dreaden E.C., Huang X., El-Sayed I.H., Chu H., Pushpanketh S., et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008, 269:57-66.
5. Okuno T., Kato S., Hatakeyama Y., Okajima J., Maruyama S., Sakamoto M., et al. Photothermal therapy of tumors in lymph nodes using gold nanorods and near-infrared laser light. J. Control. Release 2013, 172:879-884.
6. El-Sayed I.H., Huang X., El-Sayed M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 2006, 239:129-135.
7. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem. Photobiol. 2006, 82:412-417.
8. Vera J., Bayazitoglu Y. Gold nanoshell density variation with laser power for induced hyperthermia. Int. J. Heat. Mass. Tran. 2009, 52:564-573.
9. Takahashi H., Niidome Y., Niidome T., Kaneko K., Kawasaki H., Yamada S. Modification of gold nanorods using phospatidylcholine to reduce cytotoxicity. Langmuir 2006, 22:2-5.
10. Kennedy L.C., Bickford L.R., Lewinski N.A., Coughlin A.J., Hu Y., Day E.S., et al. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 2011, 7:169-183.
11. Bjordal J.M., Bensadoun R.J., Tuner J., Frigo L., Gjerde K., Lopes-Martins R.A. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support. Care. Cancer 2011, 19:1069-1077.
12. Nelke K.H., Pawlak W., Leszczyszyn J., Gerber H. Photodynamic therapy in head and neck cancer. Postep. Hig. Med. Dosw. 2014, 68:119-128.
13. Lee S.W., Lee J.W., Chung J.H., Jo J.K. Expression of heat shock protein 27 in prostate cancer cell lines according to the extent of malignancy and doxazosin treatment. World J. Men Health 2013, 31:247-253.
14. Ciocca D.R., Cayado-Gutierrez N., Maccioni M., Cuello-Carrion F.D. Heat shock proteins (HSPs) based anti-cancer vaccines. Curr. Mol. Med. 2012, 12:1183-1197.
15. Rybinski M., Szymanska Z., Lasota S., Gambin A. Modelling the efficacy of hyperthermia treatment. J. Roy. Soc. Interface 2013, 10:20130527.
16. Torigoe T., Hirohashi Y., Yasuda K., Sato N. Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapy. Int. J. Hyperther. 2013, 29:436-441.
17. Fisher J.W., Sarkar S., Buchanan C.F., Szot C.S., Whitney J., Hatcher H.C., et al. Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res. 2010, 70:9855-9864.
18. Vankayala R., Huang Y.K., Kalluru P., Chiang C.S., Hwang K.C. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation. Small 2014, 10:1612-1622.
19. Vankayala R., Lin C.C., Kalluru P., Chiang C.S., Hwang K.C. Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. Biomaterials 2014, 35:5527-5538.
20. Rosati A., Graziano V., De Laurenzi V., Pascale M., Turco M.C. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis. 2011, 2:e141.
21. Parsell D.A., Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet. 1993, 27:437-496.
22. Rosati A., Ammirante M., Gentilella A., Basile A., Festa M., Pascale M., et al. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int. J. Biochem. Cell B 2007, 39:1337-1342.
23. Mosser D.D., Morimoto R.I. Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918.
24. Ambesajir A., Kaushik A., Kaushik J.J., Petros S.T. RNA interference: a futuristic tool and its therapeutic applications. Saudi J. Bio. Sci. 2012, 19:395-403.
25. Aagaard L., Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 2007, 59:75-86.
26. Hutter E., Fendler J.H. Exploitation of localized surface plasmon resonance. Adv. Mater. 2004, 16:1685-1706.
27. Wang B., Wang J.H., Liu Q., Huang H., Chen M., Li K., et al. Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials 2014, 35:1954-1966.
28. Hauck T.S., Jennings T.L., Yatsenko T., Kumaradas J.C., Chan W.C.W. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv. Mater. 2008, 20:3832-3838.
29. Huang P., Bao L., Zhang C., Lin J., Luo T., Yang D., et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 2011, 32:9796-9809.
30. Shen S., Tang H., Zhang X., Ren J., Pang Z., Wang D., et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
31. Xiao Y., Hong H., Matson V.Z., Javadi A., Xu W., Yang Y., et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics 2012, 2:2757-2768.
32. Kim S.B., Lee T.H., Yoon I., Shim Y.K., Lee W.K. Gold nanorod-photosensitizer complex obtained by layer-by-layer method for photodynamic/photothermal therapy in vitro. Chem. Asian J. 2015, 10:563-567.
33. Xu Y.K., He R.Y., Lin D.D., Ji M.B., Chen J.Y. Laser beam controlled drug release from Ce6-Gold nanorod composites in living cells: a FLIM Study. Nanoscale 2015, 7:2433-2441.
34. Wang N.N., Zhao Z.L., Lv Y.F., Fan H.H., Bai H.R., Meng H.M., et al. Gold nanorod-photosensitizer conjugate with extracellular pH-driven tumor targeting ability for photothermal/photodynamic therapy. Nano Res. 2014, 7:1291-1301.
35. Shi Z.Z., Ren W.Z., Gong A., Zhao X.M., Zou Y.H., Brown E.M.B., et al. Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy. Biomaterials 2014, 35:7058-7067.
36. Kim C.K., Ghosh P., Pagliuca C., Zhu Z.J., Menichetti S., Rotello V.M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J. Am. Chem. Soc. 2009, 131:1360-1361.
37. Liu X.J., Hamilton I. Adsorption of small molecules on helical gold nanorods: a relativistic density functional study. J. Comput. Chem. 2014, 35:1967-1976.
38. Shen J.L., Kim H.C., Mu C.F., Gentile E., Mai J.H., Wolfram J., et al. Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy. Adv. Healthc. Mater. 2014, 3:1629-1637.
39. Salem A.K., Searson P.C., Leong K.W. Multifunctional nanorods for gene delivery. Nat. Mater. 2003, 2:668-671.
40. Chen C.C., Lin Y.P., Wang C.W., Tzeng H.C., Wu C.H., Chen Y.C., et al. DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation. J. Am. Chem. Soc. 2006, 128:3709-3715.
41. Huang H.C., Barua S., Kay D.B., Rege K. Simultaneous enhancement of photothermal stability and gene delivery efficacy of gold nanorods using polyelectrolytes. ACS. Nano 2010, 4. 1769-1752.
42. Chakravarthy K.V., Bonoiu A.C., Davis W.G., Ranjan P., Ding H., Hu R., et al. Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10172-10177.
43. Alkilany A.M., Thompson L.B., Boulos S.P., Sisco P.N., Murphy C.J. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv. Drug Deliv. Rev. 2012, 64:190-199.
44. Xu L.G., Liu Y., Chen Z.Y., Li W., Liu Y., Wang L.M., et al. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett. 2012, 12:2003-2012.
45. Wang L.M., Lin X.Y., Wang J., Hu Z.J., Ji Y.L., Hou S., et al. Novel insights into combating cancer chemotherapy resistance using a plasmonic nanocarrier: enhancing drug sensitiveness and accumulation simultaneously with localized mild photothermal stimulus of femtosecond pulsed laser. Adv. Funct. Mater. 2014, 24:4229-4239.
46. Bonoiu A.C., Mahajan S.D., Ding H., Roy I., Yong K.T., Kumar R., et al. Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5546-5550.
47. Choi J.H., Hwang H.J., Shin S.W., Choi J.W., Um S.H., Oh B.K. A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy. Nanoscale 2015, 7:9229-9237.
48. Yang Z., Liu T., Xie Y., Sun Z., Liu H., Lin J., et al. Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer. Acta Biomater. 2015, 25:194-204.
49. Zhang W., Meng J., Ji Y., Li X., Kong H., Wu X., et al. Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system. Nanoscale 2011, 3:3923-3932.
50. Yin F., Yang C., Wang Q., Zeng S., Hu R., Lin G., et al. A light-driven therapy of pancreatic adenocarcinoma using gold nanorods-based nanocarriers for co-delivery of doxorubicin and siRNA. Theranostics 2015, 5:818-833.
51. Masood R., Roy I., Zu S., Hochstim C., Yong K.T., Law W.C., et al. Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer. Integr. Biol. Camb. 2012, 4:132-141.
52. Xiao Y., Jaskula-Sztul R., Javadi A., Xu W., Eide J., Dammalapati A., et al. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. Nanoscale 2012, 4:7185-7193.
53. Chang Y.T., Liao P.Y., Sheu H.S., Tseng Y.J., Cheng F.Y., Yeh C.S. Near-infrared light-responsive intracellular drug and siRNA release using au nanoensembles with oligonucleotide-capped silica shell. Adv. Mater. 2012, 24:3309-3314.
54. Cui D., Huang P., Zhang C., Ozkan C.S., Pan B., Xu P. Dendrimer-modified gold nanorods as efficient controlled gene delivery system under near-infrared light irradiation. J. Control Release. 2011, 152(Suppl 1):e137-9.
55. Taruttis A., Lozano N., Nunes A., Jasim D.A., Beziere N., Herzog E., et al. siRNA liposome-gold nanorod vectors for multispectral optoacoustic tomography theranostics. Nanoscale 2014, 6:13451-13456.
56. Choi J.H., Oh B.K. Development of two-component nanorod complex for dual-fluorescence imaging and siRNA delivery. J. Microbiol. Biotechnol. 2014, 24:1291-1299.
57. Ramos J., Rege K. Poly(aminoether)-gold nanorod assemblies for shRNA plasmid-induced gene silencing. Mol. Pharm. 2013, 10:4107-4119.
58. Nikoobakht B., El-Sayed M.A. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem. Mater. 2003, 15:1957-1962.
59. Gole A., Murphy C.J. Polyelectrolyte-coated gold nanorods: synthesis, characterization and immobilization. Chem. Mater. 2005, 17:1325-1330.
60. Wang J.H., Wang B., Liu Q., Li Q., Huang H., Song L., et al. Bimodal optical diagnostics of oral cancer based on rose bengal conjugated gold nanorod platform. Biomaterials 2013, 34:4274-4283.
61. Gou X.C., Liu J., Zhang H.L. Monitoring human telomere DNA hybridization and G-quadruplex formation using gold nanorods. Anal. Chim. Acta 2010, 668:208-214.
62. Zhang W., Ji Y., Meng J., Wu X., Xu H. Probing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy. PLoS One 2012, 7:e31957.
63. Park K.H., Kim S., Yang S.M., Park H.G. Detection of DNA immobilization and hybridization on gold/silver nanostructures using localized surface plasmon resonance. J. Nanosci. Nanotechnol. 2009, 9:1374-1378.
64. Ammirante M., Rosati A., Arra C., Basile A., Falco A., Festa M., et al. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7497-7502.
65. Bonaventura R., Zito F., Costa C., Giarrusso S., Celi F., Matranga V. Stress response gene activation protects sea urchin embryos exposed to X-rays. Cell Stress Chaperon 2011, 16:681-687.
66. Yunoki T., Kariya A., Kondo T., Hayashi A., Tabuchi Y. The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells. Cancer Lett. 2013, 335:52-57.
67. Kim J.A., Kim Y., Kwon B.M., Han D.C. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters. J. Biol. Chem. 2013, 288:28713-28726.
68. Cotugno R., Basile A., Romano E., Gallotta D., Belisario M.A. BAG3 down-modulation sensitizes HPV18(+) HeLa cells to PEITC-induced apoptosis and restores p53. Cancer Lett. 2014, 354:263-271.
69. Rosati A., Bersani S., Tavano F., Dalla Pozza E., De Marco M., Palmieri M., et al. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with porer survival. Am. J. Pathol. 2012, 181:1524-1529.
70. Chiappetta G., Ammirante M., Basile A., Rosati A., Festa M., Monaco M., et al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Clin. Endocr. Metab. 2007, 92:1159-1163.
71. Staibano S., Mascolo M., Di Benedetto M., Vecchione M.L., Ilardi G., Di Lorenzo G., et al. BAG3 protein delocalisation in prostate carcinoma. Tumour Biol. 2010, 31:461-469.
72. Zhu H., Liu P., Li J. BAG3: a new therapeutic target of human cancers?. Histol. Histopathol. 2012, 27:257-261.
73. Wang J., Lu Z., Wientjes M.G., Au J.L. Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 2010, 12:492-503.
74. Peer D., Lieberman J. Special delivery: targeted therapy with small RNAs. Gene Ther. 2011, 8:1127-1133.
75. Bonoiu A.C., Bergey E.J., Ding H., Hu R., Kumar R., Yong K.T. Gold nanorod-siRNA induces efficient in vivo gene silencing in the rat hippocampus. Nanomedicine Lond. 2011, 6:617-630.
76. Chvapil M. Inhibition of breast adenocarcinoma growth by intratumoral injection of lipophilic long-acting lathyrogens. Anticancer Drugs 2005, 16:201-210.
77. Li X., Chen Y., Wang M., Ma Y., Xia W., Gu H. A mesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials 2013, 34:1391-1401.
78. Heidari Z., Salouti M., Sariri R. Breast cancer photothermal therapy based on gold nanorods targeted by covalently-coupled bombesin peptide. Nanotechnology 2015, 26:195101.
79. Chuang Y.C., Lin C.J., Lo S.F., Wang J.L., Tzou S.C., Yuan S.S., et al. Dual functional AuNRs@MnMEIOs nanoclusters for magnetic resonance imaging and photothermal therapy. Biomaterials 2014, 35:4678-4687.